1Progress in research on preclinical tumorigenicity evaluation of stem cell productsJIN Zi-yi, HOU Tian-tian, ZHANG Yi-kun, HUANG Ying, GENG Xing-chao2129-21332Research progress in immunogenicity of stem cells in vitroHOU Tian-tian, JIN Zi-yi, JIANG Hua, LI Lu-lu, HUANG Ying, WANG San-long2134-21403Research progress and challenges of in vivo gene therapyWANG Shan, WANG Qiang, LIU Yan2141-21504Advance in potency assay for mesenchymal stromal cellsWANG Jin-mei, QIN Mei-rong, WANG Ping, WANG Bing2151-21605Progress and registration management of clinical research of stem cells in ChinaZHANG Kai-qiang, WANG Yue, ZHONG Wei, ZHU Hua-yuan, WANG Yuan-hui, HUANG Yi-huan, JING Yuan-hao, LI Wen-wen, YE Rong, SU Yu-wen2161-21716Advances in cardiotoxicity assessment based on hSC-CMs under CiPAZENG Yun-qian, ZHAO Qi, YANG Hao, HOU Min-bo, YANG Shu-wen, TENG Yi-yang, WANG Xi-jie2172-21797Therapeutic effect and mechanism of hUC-MSCs in experimental autoimmune encephalomyelitis miceHUANG Ying, JIN Zi-yi, HAO Xiao-fang, HOU Tian-tian, QIN Chao, ZHANG Yi-kun, GENG Xing-chao2180-21918General considerations and case analysis of nonclinical research of new drugsXU Yang-mei, WAN Jiang-fan, NI Sui-ying, HE Jing-long, XIE Lei, CHENG Bin2192-21989Discussion on collecting patient experience data in patient-focused drug developmentXIAO Meng-li, ZHAO Ying-pan, QIU Pan-bo, ZHANG Hui-e, JI Jin-jin, CHENG Yu-rong, ZHAO Meng-jie, LU Fang2199-220210Empirical study on the core competencies of clinical research coordinatorsZHANG Bang-yu, JIANG Yi-dan, ZHANG Ling2203-220811Establishment of a method for potency determination of reteplase by automatic coagulation analyzerWANG Lü-yin, BAI Bi-wei, XU Kai-xin, WANG Yu-chen, LÜ Ping, LI Yi, LI Jing2209-221612Design,synthesis and structure-activity relationship of imidazo[1,2-a]pyrimidine-based human urate transporter inhibitorsLOU Jin-fang, LI Da-wei, XU Si-cong, CHEN Qiang, ZHANG Jin-zhu, ZHANG Jian, LI Yuan-yuan, TAN Shi-jie, GUO Jun-kai, SHAO Qian, LIU Xue-song, MIAO Lei2217-222313Detection and evaluation of post-marketing cardiovascular toxicity signals associated with antibody-drug conjugates based on disproportionality analysisYIN Yue-song, JIN Hui-xin, GUO Shao-wei, XU Xiao-fei, WU Yu-pei, ZHANG Li-na, QIU Zhi-hong, LI Qing-xia2224-223214Expert consensus on the clinical application of Compound Huangbai Liquid Liniment for the treatment of perianal abscess and anal fistulaZHANG Li-ze, ZHAO Gang2233-2240